Ohio State University has brought on a former biopharma executive to lead its cancer-specific Drug Development Institute with the goal of enhancing and optimizing promising oncology research for potential deal-making before the formal tech transfer process begins.
Jeffrey Patrick became director of the university's cancer-focused Drug Development Institute in February, bringing a varied biopharma background, including most...








